The student says the gray-market blend worsened his anxiety. MOTS-c discoverer Pinchas Cohen says samples sold online held little or none of the peptide.
Recap by typeshit. Full story at Daily Bruin.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
A surgeon on social media says the FDA has received two death reports involving black-market retatrutide. No official FDA statement is linked.
With weight loss drugs now common, the Times looks at how doctors are struggling to spot eating disorders in patients.
Politico reports the guidance went to the Office of Management and Budget for review this week, the next step before any change to peptide access.
Loading…